Contribution of bacterial coinfection to severe influenza infection

Critical Care Medicine

Volumn 40, Issue 5, 2012, Pages 1664-1665

  Chertow, Daniel S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bacteria; coinfection; critical illness; influenza; pathogenesis

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EDITORIAL; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INTENSIVE CARE UNIT; LENGTH OF STAY; MIXED INFECTION; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VIRUS REPLICATION;

BACTERIAL INFECTIONS; COINFECTION; CRITICAL ILLNESS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS;

EID: 84860257772     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182451fd8     Document Type: Editorial

References (16)

1. Morens DM, Taubenberger JK, Fauci AS: Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-970
2. Sheng ZM, Chertow DS, Ambroggio X, et al: Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proc Nat Acad Sci USA 2011; 108: 16416-16421
3. Estenssoro E, Rios FG, Apezteguia C, et al: Pandemic 2009 Influenza A (H1N1) in Argentina: A study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010; 182:41-48
4. Kumar A, Zarychanski R, Pinto R, et al: Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302:1872-1879
5. Gill JR, Sheng ZM, Ely SF, et al: Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010; 134:235-243
6. Viasus D, Pano-Pardo JR, Pachon J, et al: Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2011; 17:738-746
7. Rice TW, Rubinson L, Uyeki TM, et al: Critical illness from 2009 pandemic Influenza A virus and bacterial coinfection in the United States. Crit Care Med 2012; 40:1487-1498
8. Pittet LA, Hall-Stoodley L, Rutkowski MR, et al: Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2010; 42:450-460
9. Ramphal R, Small PM, Shands JW Jr, et al: Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation. Infect Immun 1980; 27:614-619
10. Takase H, Nitanai H, Yamamura E, et al: Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus. Microbiol Immunol 1999; 43:905-907
11. Kash JC, Walters K, Davis AS, et al: Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumonia coinfection is associated with loss of murine lung repair responses. MBio 2011; 2:e00172-173
12. Tashiro M, Ciborowski P, Reinacher M, et al: Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology 1987; 157:421-430
13. Tashiro M, Ciborowski P, Klenk HD, et al: Role of Staphylococcus protease in the development of influenza pneumonia. Nature 1987; 325:536-537
14. Yu H, Feng Z, Uyeki TM, et al: Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011; 52:457-465
15. Meehan TP, Fine MJ, Krumholz HM, et al: Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278:2080-2084
16. Houck PM, Bratzler DW, Nsa W, et al: Antibiotic administration in community-acquired pneumonia. Chest 2004; 126:320-321